Organ Preservation Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Organ Preservation 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Accord ing  to  the  l a t es t  repor t  by  I MARC Group,  t i t l ed  " Organ Preservat i on  
Market :  G l oba l  Indust ry  T rends ,  Share ,  S ize ,  Growth ,  O pportun i ty  and  
Forecast  2024-2032 ,"  t he  g loba l  o rgan  p reserva t ion  marke t  s i ze  reached  US$ 
187 .9  M i l l i on  in  2023.
Report Organ  p reserva t i on  re fe rs  t o  t he  m et hod  o f  conserv ing  hea l thy  o rgans  to  be  
fu r the r  u t i l i zed  fo r  o rgan  t ransp lan t a t ion .  I t  i s  an  essen t i a l  t echn ique  tha t  he lps  i n  
ma in t a in ing  the  f unc t ion ing  o f  t i s sues  and  o rgans  so  tha t  t he  g ra f t  can  func t i on  a t  
Highlight and re -per fus ion .  Some o f  t he  common p rese rva t ion  techn iques  i nc lude  hypot he rm ic  
mach ine  pe r f us ion ,  s ta t i c  co ld  s to rage ,  and  normot hermic  mach ine  pe r f us ion .  
Description These  met hods  a id  i n  p rov id ing  su f f i c ien t  oxygen  and  nu t r i t i on  tha t  he lp  i n  
reduc ing  the  chances  o f  pos t - t ransp lan t a t ion  in fec t ions .  A long w i th  th i s ,  i t  a l so  
a ids  in  improv ing  t he  su rv i va l  r a tes  and  morb id i t y  among pa t ien ts  a f t e r  t he  
t r ansp lan ta t ion .
Request  fo r  a  PDF  sample  o f  th i s  repor t :  
ht tps : / / www. imarcgroup .com/o rgan-prese rva t ion -marke t / reques tsamp le
Report Description
G lo b a l  O r g a n  P r e s e r v a t io n  M a r k e t  T r e n d s :
T h e  g l o b a l  m a r k e t  i s  p r i m a r i l y  d r i v e n  b y  t h e  r i s i n g  i n c i d e n c e s  o f  o r g a n  f a i l u r e  a m o n g  t h e  m a s s e s .  T h i s  i s  s u p p o r t e d  b y  t h e  
i n c r e a s i n g  p r e v a l e n c e  o f  c h r o n i c  i l l n e s s e s  a m o n g  i n d i v i d u a l s ,  a l o n g  w i t h  t h e  g r o w i n g  g e r i a t r i c  p o p u l a t i o n .  M o r e o v e r ,  s i g n i f i c a n t  
i n v e s t m e n ts  b y  p r i v a t e  a n d  p u b l i c  f i r m s  t o  u p g r a d e  t h e  e x i s t i n g  h e a l t h c a r e  i n f r a s t r u c t u r e  i s  f a v o r a b l y  i m p a c t i n g  t h e  m a r k e t .  I n  l i n e  
w i t h  t h i s ,  t h e  w i d e s p r e a d  u t i l i z a t i o n  o f  p r e s e r v a t i o n  m e th o d s  f o r  c o n d u c t i n g  e x p e r i m e n ta l  s t u d i e s  a n d  c l i n i c a l  t r i a l s  i n  m e d i c a l  
i n s t i t u t e s  i s  c r e a t i n g  a  p o s i t i v e  m a r k e t  o u t l o o k .  A d d i t i o n a l l y ,  c o n t i n u o u s  t e c h n o l o g i c a l  a d v a n c e m e n ts  i n  o r g a n  p r e s e r v a t i o n  
t e c h n i q u e s  a r e  a c t i n g  a s  m a j o r  g r o w t h - i n d u c i n g  f a c t o r s .  
F u r t h e r m o r e ,  n u m e r o u s  i n i t i a t i v e s  a r e  u n d e r t a k e n  b y  g o v e r n m e n t  a n d  n o n - g o v e r n m e n t a l  o r g a n i z a t i o n s  ( N G O s )  o f  m u l t i p l e  
c o u n t r i e s  f o r  e n c o u r a g i n g  o r g a n  d o n a t i o n  a c t i v i t i e s  a r e  p r o v i d i n g  a  b o o s t  t o  t h e  m a r k e t .  O th e r  f a c t o r s ,  i n c l u d i n g  c o n t i n u a l  
i m p r o v e m e n ts  i n  t h e  h e a l t h c a r e  i n f r a s t r u c t u r e ,  t h e  a c c e p t a n c e  o f  t r a n s p l a n t a t i o n  p r o c e d u r e s ,  i n f l a t i n g  d i s p o s a b l e  i n c o m e  l e v e l s  o f  
t h e  m a s s e s ,  a n d  e x t e n s i v e  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  c o n d u c t e d  b y  k e y  p l a y e r s  f o r  i n t r o d u c i n g  i m p r o v e d  
p r e s e r v a t i o n  m e th o d s ,  a r e  a l s o  p o s i t i v e l y  i n f l u e n c i n g  t h e  m a r k e t .
L o o k in g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c i p a t e d  t o  r e a c h  a  v a lu e  o f  U S $  3 1 3 . 4  M i l l i o n  b y  2 0 3 2 ,  g r o w i n g  a t  a  C A G R  o f  5 . 7 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / o r g a n - p r e s e r v a t i o n - m a r k e t
Breakup by Preservation Solution:
• UW Solut ion
• Custodio l  HTK
• Perfadex
• Others
 
Breakup by Organ Donation Type:
• Liv ing Organ Donation
Report 
• Deceased Organ Donat ion
Segmentation
Breakup by Technique:
• Stat ic  Cold Storage Technique
• Hypothermic  Machine Perfus ion
• Normothermic Machine Perfus ion
• Others
Breakup by Organ Type:
• Kidney
• Liver
• Lung
• Heart
• Others
Breakup by End-User:
• Hospita ls  and C l in ics
Report • Organ Banks
Segmentation • Others
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in Amer ica
• Middle East  and Afr ica
• 21st Century Medicine
• Biol i fe Solutions
• Bridge to Li fe Ltd.
• Bristol -Myers Squibb
Competitive 
• Dr. Franz Köhler Chemie GmbH
Landscape • Essential  Pharmaceuticals.
with Key • Lifel ine Scientifi c
• OrganOx
Players
• Paragonix Technologies
• TransMedics
• Waters Medical Systems
• Xvivo Perfusion
What was the size of the global organ preservation 
market in 2023?
What is the expected growth rate of the global 
organ preservation market during 2024-2032?
Key 
Questions What are the key factors driving the global organ preservation market?
Answered in 
What has been the impact of COVID-19 on the 
the Report global organ preservation market?
What is the breakup of the global organ 
preservation market based on the preservation 
solution?
What is the breakup of the global organ 
preservation market based on the organ donation 
type?
What is the breakup of the global organ 
preservation market based on the technique?
What is the breakup of the global organ 
preservation market based on the organ type?
Key 
What is the breakup of the global organ 
Questions preservation market based on the end-user?
Answered in 
What are the key regions in the global organ 
the Report preservation market?
Who are the key players/companies in the global 
organ preservation market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  O r g a n  P r e s e r v a t i o n  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r e s e r v a t i o n  S o l u t i o n
    6 . 1     U W  S o l u t i o n
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     C u s t o d i o l  H T K
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     P e r f a d e x
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     O t h e r s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  O r g a n  D o n a t i o n  T y p e
    7 . 1     L i v i n g  O r g a n  D o n a t i o n
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     D e c e a s e d  O r g a n  D o n a t i o n
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  T e c h n i q u e
    8 . 1     S t a t i c  C o l d  S t o r a g e  T e c h n i q u e
Table of         8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     H y p o t h e r m i c  M a c h i n e  P e r f u s i o n
Contents         8 . 2 . 1  M a r k e t  T r e n d s        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     N o r m o t h e r m i c  M a c h i n e  P e r f u s i o n
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     O t h e r s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  O r g a n  T y p e
    9 . 1     K i d n e y
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     L i v e r
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / o rga n - p re s e r v a t i o n - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: